Migraine headache therapy shifts treatment focus from the head to the neck
A researcher at Murdoch University has investigated a migraine headache therapy which shifts treatment focus from the head to the neck.
Oct 26, 2016
0
19
A researcher at Murdoch University has investigated a migraine headache therapy which shifts treatment focus from the head to the neck.
Oct 26, 2016
0
19
"Effect of Different Meditation Types on Migraine Headache Medication Use," an article recently published in Behavioral Medicine, examines whether or not, and to what extent, a combination of spiritual meditation and migraine ...
Sep 8, 2016
0
13
Child abuse and neglect are, sadly, more common than you might think. According to a 2011 study in JAMA Pediatrics, more than five million U.S. children experienced confirmed cases of maltreatment between 2004 and 2011. The ...
Jul 12, 2016
0
24
Women who suffer from migraine headaches have a slightly increased risk of developing cardiovascular disease in later life. A team of researchers led by Prof. Tobias Kurth, Head of the Institute of Public Health (IPH) at ...
Jun 14, 2016
0
3
Teva Pharmaceutical said Monday that it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied. The company advised that anyone who has its patch should not use it.
Jun 13, 2016
0
0
Light sensitivity, or photophobia, is a frequent symptom of migraine headaches, which affect nearly 15 percent of the world's population. A new study, led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and ...
May 17, 2016
0
236
About 38 million Americans suffer from migraines in the United States, according to the Migraine Research Foundation. The most commonly used and effective classes of medication, triptans and DHE (Dihydroergotamine), however, ...
May 10, 2016
1
27
(HealthDay)—The prevalence of migraine headache is elevated in patients with cardiac syndrome X (CSX) compared to patients with coronary artery disease or healthy controls, according to a research letter published in the ...
Apr 26, 2016
0
2
The American Academy of Neurology (AAN) has updated its 2008 guidelines on the use of botulinum toxin for spasticity, cervical dystonia, blepharospasm and migraine headache, based on recent research. The guideline is published ...
Apr 18, 2016
0
6
(HealthDay)—Women are a majority of the 4.4 million Americans over age 40 who are visually impaired or blind, Prevent Blindness says.
Apr 12, 2016
0
3